Financials ChemoMetec A/S

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 10:28:55 2024-05-01 am EDT 5-day change 1st Jan Change
295.5 DKK -1.17% Intraday chart for ChemoMetec A/S +1.37% -23.92%

Valuation

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Capitalization 1 14,679 13,174 8,110 5,203 - -
Enterprise Value (EV) 1 14,679 13,174 7,800 4,860 4,800 4,741
P/E ratio 166 x 82.6 x 45.4 x 38.9 x 33.2 x 27.5 x
Yield - 0.53% - 2.17% 2.68% 2.84%
Capitalization / Revenue - 30.8 x 18.3 x 12.9 x 11.1 x 9.54 x
EV / Revenue - 30.8 x 17.6 x 12 x 10.2 x 8.69 x
EV / EBITDA - 59.1 x 31.1 x 26.3 x 21.5 x 17.8 x
EV / FCF - - 68.8 x 46.7 x 35 x 30.9 x
FCF Yield - - 1.45% 2.14% 2.86% 3.23%
Price to Book - - 15.2 x 8.71 x 7.67 x 8.48 x
Nbr of stocks (in thousands) 17,402 17,402 17,402 17,402 - -
Reference price 2 843.5 757.0 466.0 299.0 299.0 299.0
Announcement Date 9/17/21 9/15/22 9/13/23 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Net sales 1 - 427.2 442.3 403.5 470.7 545.3
EBITDA 1 - 222.9 251 185 223 266.7
EBIT 1 - 202.9 230.6 176.3 201 242
Operating Margin - 47.48% 52.13% 43.7% 42.71% 44.38%
Earnings before Tax (EBT) 1 - - 230.4 177 201 242
Net income 1 88.35 159.5 178.7 133.8 156.9 189
Net margin - 37.34% 40.4% 33.15% 33.34% 34.66%
EPS 2 5.080 9.160 10.27 7.694 9.016 10.87
Free Cash Flow 1 - - 113.3 104 137.3 153.3
FCF margin - - 25.62% 25.77% 29.18% 28.12%
FCF Conversion (EBITDA) - - 45.15% 56.22% 61.58% 57.5%
FCF Conversion (Net income) - - 63.43% 77.75% 87.52% 81.12%
Dividend per Share 2 - 4.000 - 6.500 8.000 8.500
Announcement Date 9/17/21 9/15/22 9/13/23 - - -
1DKK in Million2DKK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 S1 2025 S2
Net sales 1 108.1 199.3 98.9 106 203 216 224
EBITDA 1 51.6 93.1 43.5 49.7 91 101 96
EBIT 1 - 84.65 43.5 49.7 82 92 86
Operating Margin - 42.47% 43.98% 46.86% 40.39% 42.59% 38.39%
Earnings before Tax (EBT) - 89.02 - - 83 93 88
Net income 1 - 70.56 43.5 49.7 65 72 68
Net margin - 35.4% 43.98% 46.86% 32.02% 33.33% 30.36%
EPS 2 - 4.050 2.500 2.850 3.720 4.160 3.920
Dividend per Share - - - - - - -
Announcement Date 2/5/24 2/5/24 - - - - -
1DKK in Million2DKK
Estimates

Balance Sheet Analysis

Fiscal Period: June 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - 309 343 403 463
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - 113 104 137 153
ROE (net income / shareholders' equity) - 51.4% 39.5% 23.6% 24.6% 26.7%
ROA (Net income/ Total Assets) - - - 20.5% 20.5% 21.8%
Assets 1 - - - 652.1 764.9 866.7
Book Value Per Share 2 - - 30.60 34.30 39.00 35.30
Cash Flow per Share 2 - 10.20 8.860 8.000 10.00 11.90
Capex 1 - - 40.8 47.6 43.1 53.4
Capex / Sales - - 9.23% 11.79% 9.16% 9.79%
Announcement Date 9/17/21 9/15/22 9/13/23 - - -
1DKK in Million2DKK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
299 DKK
Average target price
462.5 DKK
Spread / Average Target
+54.68%
Consensus
  1. Stock Market
  2. Equities
  3. CHEMM Stock
  4. Financials ChemoMetec A/S